Prenosis
Transforming clinical diagnosis with predictive intelligence.
Transforming clinical diagnosis with predictive intelligence.
Prenosis is a biopharma and health care startup founded in 2014 with the slogan "Transforming clinical diagnosis with predictive intelligence." The company's core focus is transforming clinical diagnosis through the use of artificial intelligence that utilizes a holistic approach to molecular and clinical data.
Based in the United States, Prenosis recently secured a significant $4.80M grant investment on 12 July 2023. The investment came from the National Institute of General Medical Science, highlighting the company's recognition and support from reputable industry players.
Overall, Prenosis appears to be an innovative player in the biopharma and healthcare sectors, leveraging cutting-edge technology and data analysis to improve the accuracy and efficiency of clinical diagnosis. Their recent investment is a testament to their potential and the confidence of notable investors in their mission.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $4.80M | 1 | National Institute of General Medical Science | 12 Jul 2023 |
| Venture Round | Unknown | 1 |
|
09 Mar 2022 |
| Grant | $4.30M | 1 | Defense Threat Reduction Agency (DTRA) | 17 Nov 2021 |
| Grant | $704.53K | 1 |
|
18 Sep 2018 |
| Grant | $150.00K | 1 |
|
10 Jul 2017 |
We care about your data, and we'd love to use cookies make your experience better.
